News
Demis Hassabis of Google DeepMind predicts AI can end all diseases soon. He says AI can drastically cut drug development time ...
Demis Hassabis, DeepMind's founder and chief executive, has taken the same roles at Isomorphic Labs on an interim basis, saying in a blog post that the new company will "reimagine the entire drug ...
Hassabis pointed out the potential of AI to transform medicine by significantly lessening the time and expense of drug development.
Nobel laureate and DeepMind CEO Demis Hassabis envisions a future where AI revolutionizes healthcare by drastically accelerating drug development—from years to weeks—and potentially curing all ...
Isomorphic Labs has raised a whopping $600 million to ... The start-up – which has emerged from Google parent Alphabet's DeepMind project and is led by DeepMind founder Sir Demis Hassabis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results